title: Tumor necrosis factor receptor 1-dependent depletion of mucus in immature small intestine: a potential role in neonatal necrotizing enterocolitis.
abstract: Necrotizing enterocolitis (NEC) is a leading cause of morbidity and mortality in premature infants. NEC is believed to occur when intestinal bacteria invade the intestinal epithelial layer, causing subsequent inflammation and tissue necrosis. Mucins are produced and secreted by epithelial goblet cells as a key component of the innate immune system and barrier function of the intestinal tract that help protect against bacterial invasion. To better understand the role of mucins in NEC, we quantified the number of mucus-containing small intestinal goblet cells present in infants with NEC and found they had significantly fewer goblet cells and Paneth cells compared with controls. To test whether inflammation has a developmentally dependent effect on intestinal goblet cells, TNF-α was injected into mice at various stages of intestinal development. TNF-α caused a loss of mucus-containing goblet cells only in immature mice and induced Muc2 and Muc3 mRNA upregulation only in mature ileum. Only minimal changes were seen in apoptosis and in expression of markers of goblet cell differentiation. TNF-α increased small intestinal mucus secretion and goblet cell hypersensitivity to prostaglandin E2 (PGE(2)), a known mucus secretagogue produced by macrophages. These TNF-α-induced changes in mucus mRNA levels required TNF receptor 2 (TNFR2), whereas TNF-α-induced loss of mucus-positive goblet cells required TNFR1. Our findings of developmentally dependent TNF-α-induced alterations on intestinal mucus may help explain why NEC is predominantly found in premature infants, and TNF-α-induced alterations of the intestinal innate immune system and barrier functions may play a role in the pathogenesis of NEC itself.
authors: Dept. of Pediatrics, Div. of Neonatology, Nashville, TN 37232-0696, USA. steven.j.mcelroy@vanderbilt.edu
authors: Steven J
authors: SJ
authors: McElroy
authors: Lawrence S
authors: LS
authors: Prince
authors: Jörn-Hendrik
authors: JH
authors: Weitkamp
authors: Jeff
authors: J
authors: Reese
authors: James C
authors: JC
authors: Slaughter
authors: D Brent
authors: DB
authors: Polk
mesh_terms: D000818:Animals; D020345:Enterocolitis, Necrotizing / Q000473:pathology*; D020397:Goblet Cells / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007413:Intestinal Mucosa / Q000473:pathology; D007421:Intestine, Small / Q000187:drug effects / Q000473:pathology*; D051379:Mice; D055262:Mucin-2 / Q000378:metabolism; D055263:Mucin-3 / Q000378:metabolism; D009077:Mucins; D009093:Mucus / Q000378:metabolism; D019879:Paneth Cells / Q000378:metabolism / Q000473:pathology; D050783:Proto-Oncogene Proteins c-ets / Q000096:biosynthesis; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000502:physiology*; D047889:Receptors, Tumor Necrosis Factor, Type II / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: C524625:MUC2 protein, human; C524652:MUC3A protein, human; D055262:Mucin-2; D055263:Mucin-3; D009077:Mucins; D050783:Proto-Oncogene Proteins c-ets; D047888:Receptors, Tumor Necrosis Factor, Type I; D047889:Receptors, Tumor Necrosis Factor, Type II; C403974:SPDEF protein, human; D014409:Tumor Necrosis Factor-alpha